No efficacy or safety concerns regarding the product candidate were raised by the …
Valeant has achieved this through a multitude of asset sales ... The Next Canadian Superbrand You've Never Heard of... This small-cap stock is "Hidden in Plain …
Cmt Asset Management Ltd acquired 37,635 shares as Valeant Pharmaceuticals Intl (VRX)'s stock declined 15.71%. The Private Management Group Inc holds …
And while Valeant still has to refile ... depending whther investors were long or …
To that end, what’s the realistic upside potential for VRX stock? From around $16 per share, Valeant can reach $20 in the next 12 to 18 months, delivering 25% returns. And that projection is conservative to the extent the company can meet …
10 stocks we like better than Valeant Pharmaceuticals When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the …
NWI7d
This article analyzes Valeant's financial status and comes to the conclusion that the stock is likely overvalued and may be worthless. It also concludes that VRX's debt may not pay off at 100 cents on the dollar. Perhaps we are in Wonderland. …
Valeant’s stock lost 12% against the industry’s gain of 5.5%. The company’s adjusted earnings per share of $1.05 beat the Zacks Consensus Estimate of 97 …
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong time in the pre-market hours, which is interesting considering that the company reported its second quarter earnings, and while the report showed a further …